Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin

Blood

Volumn 95, Issue 12, 2000, Pages 3742-3749

  Choi, Ilseung ^b   Muta, Koichiro ^a   Wickrema, Amittha ^b   Krantz, Sanford B ^b   Nishimura, Junji ^b   Nawata, Hajime ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; DNA FRAGMENT; ERYTHROPOIETIN; FAS ANTIGEN; GAMMA INTERFERON; LIPOCORTIN 5; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; COLONY FORMING UNIT E; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034659744     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3742.012k09_3742_3749     Document Type: Article

References (44)

1. Sen GC, Lengyel P. Interferon system. J Biol Chem. 1992;267:5017.
2. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon-γ and tumor necrosis factor-α suppress both early and late stage of hematopoiesis and induce programmed cell death. J Cell Physiol. 1995;165:538.
3. Nakao S, Yamaguchi M, Shiobara S. Interferon-γ gene expression in unstimulated bone marrow mononuclear cells predicts the response to cyclosporine therapy in aplastic anemia. Blood. 1992;79:2532.
4. Nistico A, Young NS. γ-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med. 1994;120:463.
5. Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol. 1994;87:243.
6. Dai CH, Price JO, Brunner T, Krantz SB. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood. 1998;91:1235.
7. Maciejewski J, Selleri C, Anderson A, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995; 85:3183.
8. Taniguchi S, Dai CH, Price JO, Krantz SB. Interferon γ downregulates stem cell factor and erythropoietin receptors but not insulinlike growth factor-1 receptors in human erythroid colony-forming cells. Blood. 1997;90:2244.
9. Sato T, Selleri C, Young NS, Maciejewski JP. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-γ due to phosphorylation of Stat1 and Stat3. Blood. 1997;90:4749.
10. Selleri C, Maciejewski JP, Sato T, Young NS. Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood. 1996;87:4149.
11. Dai CH, Krantz SB, Kollar K, Price JO. Stem cell factor can overcome inhibition of highly purified human burst-forming units-erythroid by interferonγ. J Cell Physiol. 1995;165:323.
12. Zoumbos NC, Baranski B, Young NS. Different haematopoietic growth factors have a different capacity in overcoming the in vitro interferon gamma-induced suppression of bone marrow progenitor cells. Eur J Haematol. 1990;44:282.
13. Muta K, Krantz SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulinlike growth factor 1 as well as erythropoietin. J Cell Physiol. 1993;156:264.
14. Brugger W, Mocklin W, Heimfeld S, Berenson R, Mertelsmann R, Kanz L. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 β (IL-1β), IL-6, IL-3, interferon-γ, and erythropoietin. Blood. 1993;81:2579.
15. Caux C, Moreau I, Saeland S, Banchereau J. Interferon-γ enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells. Blood. 1992;79:2628.
16. Shiohara M, Koike K, Nakahara T. Synergism of interferon-γ and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. Blood. 1993;81:1434.
17. Sawada K, Krantz SB, Kans JS, et al. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest. 1987;80:357.
18. Sawada K, Krantz SB, Dai CH, et al. Purification of human blood burst-forming units-erythroid and demonstration of the evolution on erythropoietin receptors. J Cell Physiol. 1990;142:219.
19. Koury MJ, Moundurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science. 1990; 248:378.
20. Boyer SH, Bishop TR, Rogers OC, Noyes AN, Frelin LP, Hobbs S, Roles of erythropoietin, insulinlike growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood. 1992;80: 2503.
21. Muta K, Krantz SB, Boundurant MC, Wickrema A. Distinct roles of erytheropoietin, insulinlike growth factor 1, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest. 1994;94:34.
22. Gregoli PA, Bondurant MC. The roles of Bcl-XL and apopain in the control of erythropoiesis by erythropoietin. Blood. 1997;90:630.
23. Bentito A, Silva M, Grillot D, Nunez G, Fernandez-Luna JL. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-xL. Blood. 1996;87:3837.
24. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood. 1996;88: 1576.
25. Terui Y, Furukawa Y, Kikuchi J, Iwase S, Hatake K, Miura Y. Bcl-x is a reguratory factor of apoptosis and differentiation in megakaryocytic lineage cells. Exp Hematol. 1998;26:236.
26. Schlegel J, Peters I, Orrenius S, et al. CPP32/ apopain is a key interleukin 1 β-converting enzyme like protease involved in Fas-mediated apoptosis. J Biol Chem. 1996;271:1841.
27. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.
28. Hirata H, Takahashi A, Kobayashi S, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 1998;187:587.
29. Wickrema A, Chen F, Namin F, et al. Defective expression of the SHP-1 phosphatase in polycythemia vera. Exp Hematol. 1999;27:1124.
30. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulinlike growth factor 1 and /or insulin for erythroid development. J Clin Invest. 1989;83:1701.
31. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415.
32. Motomura S, Fukushima K, Nishitani H, Nawata H, Nishimoto T. A hamster temperature-sensitive G1 mutant, tsBN250, has a single-point mutation in histidyl-tRNA synthetase that inhibits an accumulation of cyclin D1. Genes Cells 1996;1:1101.
33. Dai CH, Krantz SB. Interferon γ induces upregulation and activation of capases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood. 1999;93:3309.
34. Taniguchi S, Dai CH, Krantz SB. Specific binding of interferon-γ to high-affinity receptors on human erythroid colony-forming cells. Exp Hematol. 1997;25:193.
35. Baxter GT, Kuo RC, Jupp OJ, Vandenabeele P, MacEwan DJ. Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem. 1999;274:9539.
36. Su L, David M. Inhibition of B-cell receptor-mediated apoptosis by IFN. J Immunol. 1999;162: 6317.
37. Shiratsuchi M, Muta K, Umemura T, Nishimura J, Nawata H, Kozuru M. Telomerase activity in myeloma cells is closely related to cell-cycle status, but not to apoptotic signals induced by interferon-α. Leuk Lymphoma. 1999;34:349.
38. Nagata S. Apoptosis by death factor. Cell. 1997; 88:355.
39. Maria D, Testa U, Luchetti L, et al. Apoptotic role of Fas-Fas ligand system in the regulation of erythropoiesis. Blood. 1999;93:796.
40. Tschopp J, Irmler M, Thorne M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol. 1998;10:552.
41. Franke TF, Cantley LC. A bad kinase makes good. Nature. 1997;390:116.
42. Sui X, Krantz SB, You M, Zhao Z. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood. 1998;92:1142.
43. Oda A, Sawada K, Druker BJ, et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood. 1998;92:443.
44. Haseyama Y, Sawada K, Oda A, et al. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood. 1999;94:1568.